dr. HM (Hedwig) Blommestein

Erasmus School of Health Policy & Management

Associate professor | Health Technology Assessment (HTA)

Email: blommestein@eshpm.eur.nl

Pure profile

Work

Lucas F. van Schaik, Brigitte Maes, Pieter Jan Volders, Guy Froyen, Philippe Aftimos, Evandro de Azambuja, Hedwig M. Blommestein, Wim H. van Harten & Valesca P. Retèl (2025) - Economic Evaluation of Comprehensive Genomic Profiling in an Advanced Solid Cancer Population - JAMA network open, 8 (12) - doi: 10.1001/jamanetworkopen.2025.48538 - [link]
Noor Wortelboer, Seamus Kent, Inge R. Konings, Annemiek van Ommen-Nijhof, Vincent van der Noort, Esther van den Pol, Cristina Guerrero Páez, Marlies L. van Bekkum, Franchette W.P.J. van den Berkmortel, Helga J. Droogendijk, Danny Houtsma, Hendrika M. Oosterkamp, Annemieke van der Padt-Pruijsten, Ester J.M. Siemerink, Jolien Tol, Annette A. van Zweeden, A. Elise van Leeuwen-Stok, Gabe S. Sonke, Agnes Jager & Hedwig Blommestein (2025) - Health economic outcomes and costs of CDK4/6 inhibitor use in first- versus second-line for advanced breast cancer: A cost-effectiveness analysis of the phase 3 SONIA trial - European Journal of Cancer, 231 - doi: 10.1016/j.ejca.2025.116051 - [link]
Maarten R. Seefat, Niek G. van der Maas, Kazem Nasserinejad, Bronno van der Holt, Anders Waage, Ulf Henrik Mellqvist, Annette Juul Vangsted, Anna J.T. Smit, Febe Smits, Paula F. Ypma, Niels W.C.J. van de Donk, Hedwig M. Blommestein, Jan J. Cornelissen, David G.J. Cucchi, Sonja Zweegman & Jurjen Versluis (2025) - Adaptive designs in randomized clinical trials: reanalysis of the HOVON87/NMSG18 multiple myeloma trial - EClinicalMedicine, 90 - doi: 10.1016/j.eclinm.2025.103605 - [link]
Diego A. Larrotta-Castillo, Hedwig M. Blommestein, Britt Kunnen, Joan J. Penninkhof, Agustinus J.A.J. van de Schoot, Mischa S. Hoogeman & Steven F. Petit (2025) - Cost-benefit analysis of advanced CBCT imaging: Incremental costs and savings - Radiotherapy and Oncology, 211 - doi: 10.1016/j.radonc.2025.111106 - [link]
Yi Hsuan Chen, Michiel Kroesen, Mischa S. Hoogeman, Matthijs M. Versteegh, Carin A. Uyl-de Groot & Hedwig M. Blommestein (2025) - Reply to comment on Treatment-related toxicity, utility and patient-reported outcomes of head and neck cancer patients treated with proton therapy: A longitudinal study - Clinical and Translational Radiation Oncology, 54 - doi: 10.1016/j.ctro.2025.101013 - [link]
Saskia de Groot, Hedwig M. Blommestein, Brenda Leeneman, Carin A. Uyl-de Groot, John B.A.G. Haanen, Michel W.J.M. Wouters, Maureen J.B. Aarts, Franchette W.P.J. van den Berkmortel, Willeke A.M. Blokx, Marye J. Boers-Sonderen, Alfons J.M. van den Eertwegh, Jan Willem B. de Groot, Geke A.P. Hospers, Ellen Kapiteijn, Olivier J. van Not, Astrid A.M. van der Veldt, Karijn P.M. Suijkerbuijk & Pieter H.M. van Baal (2025) - Development of a Decision Model to Estimate the Outcomes of Treatment Sequences in Advanced Melanoma - Medical Decision Making, 45 (3), 302-317 - doi: 10.1177/0272989X251319338 - [link]
Hedwig M. Blommestein, Saskia de Groot, Brenda Leeneman, Carin A. Uyl-de Groot, John B.A.G. Haanen, Michel W.J.M. Wouters, Maureen J.B. Aarts, Franchette W.P.J. van den Berkmortel, Willeke A.M. Blokx, Marye J. Boers-Sonderen, Alfons J.M. van den Eertwegh, Jan Willem B. de Groot, Geke A.P. Hospers, Ellen Kapiteijn, Olivier J. van Not, Astrid A.M. van der Veldt, Karijn P.M. Suijkerbuijk & Margreet G. Franken (2025) - Cost-effectiveness of treatment sequences for BRAF-mutant advanced melanoma in the Netherlands using a health economic model - European Journal of Cancer, 218 - doi: 10.1016/j.ejca.2024.115071 - [link]
Yi Hsuan Chen, Michiel Kroesen, Mischa Hoogeman, Matthijs Versteegh, Carin Uyl-de Groot & Hedwig M. Blommestein (2025) - Treatment-related toxicity, utility and patient-reported outcomes of head and neck cancer patients treated with proton therapy: A longitudinal study - Clinical and Translational Radiation Oncology, 51 - doi: 10.1016/j.ctro.2025.100913 - [link]
Gabe S. Sonke, Annemiek van Ommen-Nijhof, , Noor Wortelboer, Vincent van der Noort, Astrid C.P. Swinkels, Hedwig M. Blommestein, Cristina Guerrero Paez, Linda Mol, Aart Beeker, Karin Beelen, Lisanne C. Hamming, Joan B. Heijns, Aafke H. Honkoop, Paul C. de Jong, Quirine C. van Rossum-Schornagel, Christa van Schaik-van de Mheen, Jolien Tol, Cathrien S. Tromp-van Driel, Suzan Vrijaldenhoven, A. Elise van Leeuwen-Stok, Inge R. Konings & Agnes Jager (2024) - Early versus deferred use of CDK4/6 inhibitors in advanced breast cancer - Nature, 636 (8042), 474-480 - doi: 10.1038/s41586-024-08035-2 - [link]
Christine Bennink, Mirian Brink, Saskia F.A. Duijts, Hans Scheurer, Pieter Sonneveld & Hedwig M. Blommestein (2024) - Changes in income and employment after diagnosis among patients with multiple myeloma in The Netherlands - Clinical Lymphoma, Myeloma and Leukemia, 24 (9), 604-610 - doi: 10.1016/j.clml.2024.04.004 - [link]